Seattle, WA, United States of America

Chad MacDonald

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Healionics Corporation. Active years: 2019-2020.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chad MacDonald: Innovator in Vascular Graft Technology

Introduction

Chad MacDonald is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of vascular grafts and implantable devices. With a total of 2 patents, his work focuses on improving the performance and infection resistance of these critical medical devices.

Latest Patents

Chad's latest patents include innovative designs for implantable devices. One of his notable inventions is a "Corrugated microporous tissue interface for improved performance and infection resistance of vascular grafts and other implantable devices." This invention features a microporous sheath layer with a corrugated outer surface, aimed at reducing the risk of infection or stenosis in devices such as vascular grafts and access ports for hemodialysis.

Career Highlights

Chad MacDonald has established himself as a key figure in the biomedical field through his work at Healionics Corporation. His expertise in developing advanced materials for medical applications has positioned him as a leader in innovation within the industry.

Collaborations

Chad has collaborated with several talented individuals, including Andrew J Marshall and Brandt Scanlan. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Chad MacDonald is a dedicated inventor whose work in vascular graft technology has the potential to significantly enhance patient outcomes. His innovative patents reflect his commitment to improving medical devices and addressing critical healthcare challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…